Insulin resistance in insulin-resistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism

Comparative Medicine

Volumn 59, Issue 5, 2009, Pages 449-458

  Guosheng, Li ^a   Xuhan, Liu ^a   Hua, Zhu ^a   Lan, Huang ^a   Yali, Liu ^a   Chunmei, Ma ^a   Chuan, Qin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INSULIN; LIVER X RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; SYRIAN HAMSTER;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; MESOCRICETUS; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORPHAN NUCLEAR RECEPTORS; PPAR ALPHA; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 70450081707     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. 2005. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 68:2562-2571. (Pubitemid 43251001)
2. De Fourmestraux V, Neubauer H, Poussin C, Farmer P, Falquet L, Burcelin R, Delorenzi M, Thorens B. 2004. Transcript profiling suggests that differential metabolic adaptation of mice to a high-fat diet is associated with changes in liver to muscle lipid fluxes. J Biol Chem 279:50743-50753. (Pubitemid 40017812)
3. Finck BN, Kelly DP. 2006. PGC1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116:615-622.
4. Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H, Toyoshima H, Fukamizu A, Yamada N. 2004. SREBPs suppress IRS2-mediated insulin signalling in the liver. Nat Cell Biol 6:351-357. (Pubitemid 38584825)
5. Ip E, Farrell G, Hall P, Robertson G, Leclercq I. 2004. Administration of the potent PPARα agonist, Wy14643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39:1286-1296. (Pubitemid 38569050)
6. Jeon JR, Kim JY. 2006. Effects of pine-needle extract on differentiation of 3T3L1 preadipocytes and obesity in high-fat diet fed rats. Biol Pharm Bull 29:2111-2115.
7. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H. 2005. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 54:2404-2414.
8. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein 1c. J Biol Chem 277:9520-9528. (Pubitemid 34953041)
9. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. 1993. Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992.
10. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM. 2005. Hyperlipidemic effects of dietary saturated fats mediated through PGC1β reactivation of SREBP. Cell 120:261-273. (Pubitemid 40174768)
11. 1 method. Methods 25:402-408.
12. Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R, Reaven GM. 1998. Nongenetic mouse models of noninsulin-dependent diabetes mellitus. Metabolism 47:663-668. (Pubitemid 28265168)
13. Matsumoto M, Han S, Kitamura T, Accili D. 2006. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464-2472. (Pubitemid 44330145)
14. McGarry JD. 2002. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18.
15. Miserez AR, Muller PY, Barella L, Barella S, Staehelin HB, Leitersdorf E, Kark JD, Friedlander Y. 2002. Sterol-regulatory elementbinding protein (SREBP) 2 contributes to polygenic hypercholesterolaemia. Atherosclerosis 164:15-26.
16. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB. 2006. Chronic inhibition of dipeptidyl peptidase 4 with a sitagliptin analog preserves pancreatic β cell mass and function in a rodent model of type 2 diabetes. Diabetes 55:1695-1704.
17. Ponugoti B, Fang S, Kemper JK. 2007. Functional interaction of HNF4 and PGC1α in CYP7A1 regulation is inhibited by a key lipogenic activator, SREBP1c. Mol Endocrinol 21:2698-2712.
18. Samuel VT, Liu ZX, Qu XQ, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. 2004. Mechanism of hepatic insulin resistance in nonalcoholic fatty liver disease. J Biol Chem 279:32345-32353.
19. Seoane J, Trinh K, O'Doherty RM, Gómez-Foix AM, Lange AJ, Newgard CB, Guinovart JJ. 1997. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J Biol Chem 272:26972-26977.
20. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. 2000. Decreased IRS2 and increased SREBP1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophy and ob/ob mice. Mol Cell 6:77-86.
21. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE. 2002. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277:23301-23307.
22. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini A. 2006. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor α and n3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169:846-860.
23. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB. 1998. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620. (Pubitemid 28533186)
24. Unger RH, Orci L. 2000. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 24 suppl 4:S28-S32.
25. Valera A, Pujol A, Pelegrin M, Bosch F. 1994. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop noninsulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151-9154.
26. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. 1995. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 56:307-317.
27. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. 1990. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915.
28. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. 2006. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 26:3455-3467.
29. ob mice. J Biol Chem 277:19353-19357. (Pubitemid 34967441)
30. Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH. 2004. Reduced expression of peroxisome proliferator-activated receptor α may have an important role in the development of nonalcoholic fatty liver disease. J Gastroenterol Hepatol 19:799-804.